Explore the Site
Home
Latest News
AusBiotech
Events
About
Contact
Subscribe
Search
Follow Us
LinkedIn
Twitter
Instagram
BiotechDispatch
Menu
May 01, 2024
Subscribe
Login
Home
Latest News
AusBiotech
Events
About
Contact
Subscribe
Search
Sign In
Login
Forgot password?
Contact Us
Suite 9214
4 Duff Place
Deakin
ACT
2600
t. 0408 492 937
e.
contact@dailydispatch.com.au
Most Read
Mesoblast announces the appointment of new board chair
April 30, 2024 - Latest News
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
April 30, 2024 - Latest News
AusMedtechInvest keynote and panel speakers announced
April 30, 2024 - AusBiotech
Alterity Therapeutics presents new data demonstrating potential of ATH434
April 30, 2024 - Latest News
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
April 30, 2024 - Latest News
Follow Us
LinkedIn
Twitter
Instagram
New Stories
AusMedtechInvest keynote and panel speakers announced
April 30, 2024 - - AusBiotech
Mesoblast announces the appointment of new board chair
April 30, 2024 - - Latest News
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
April 30, 2024 - - Latest News
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
April 30, 2024 - - Latest News
Alterity Therapeutics presents new data demonstrating potential of ATH434
April 30, 2024 - - Latest News
AusBiotech announces incoming CEO
April 23, 2024 - - AusBiotech
Osteopore launches first first-in-human clinical trials begin in Singapore
April 23, 2024 - - Latest News